Audentes Therapeutics (BOLD) Earnings
|
Expand Research on BOLD
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +60.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/26/26  |
Q425 | N/A | -$1.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 |
Q425 | N/A | -$1.09 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | -$0.62 | -$1.09 | +$0.47 | N/A | N/A | N/A |  | | Details | |
| 8/5/25 |
Q225 | -$0.70 | -$1.02 | +$0.32 | N/A | N/A | N/A | | | Details | |
| 5/9/25 |
Q125 | $0.71 | -$1.02 | +$1.73 | N/A | N/A | N/A | | | Details | |
| 2/26/25 |
Q424 | N/A | -$0.84 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/8/24 |
Q324 | -$0.74 | -$0.73 | -$0.01 | N/A | N/A | N/A | | | Details | |
| 8/28/24 | Q224 | N/A | -$0.65 | N/A | N/A | N/A | N/A | N/A | N/A |
